A549 |
GI50 |
= |
7020.0 |
nM |
Cytostatic activity against human A549 cells after 5 days by SRB assay |
CHEMBL1811802 |
NCI-H23 |
GI50 |
= |
5400.0 |
nM |
Cytostatic activity against human NCI-H23 cells after 5 days by SRB assay |
CHEMBL1811802 |
DU-145 |
GI50 |
|
|
|
Cytostatic activity against human DU145 cells after 5 days by SRB assay |
CHEMBL1811802 |
PC-3 |
GI50 |
= |
6290.0 |
nM |
Cytostatic activity against human PC3 cells after 5 days by SRB assay |
CHEMBL1811802 |
HCT-116 |
GI50 |
= |
3740.0 |
nM |
Cytostatic activity against human HCT116 cells after 5 days by SRB assay |
CHEMBL1811802 |
HCT-15 |
GI50 |
|
|
|
Cytostatic activity against human HCT15 cells after 5 days by SRB assay |
CHEMBL1811802 |
Unchecked |
GI50 |
= |
6730.0 |
nM |
Cytostatic activity against human Hs578 cells after 5 days by SRB assay |
CHEMBL1811802 |
BT-549 |
GI50 |
> |
10000.0 |
nM |
Cytostatic activity against human BT549 cells after 5 days by SRB assay |
CHEMBL1811802 |
MT4 |
GI50 |
= |
4800.0 |
nM |
Cytostatic activity against human MT4 cells after 5 days by SRB assay |
CHEMBL1811802 |
HL-60 |
IC50 |
> |
10000.0 |
nM |
Cytotoxicity against human HL60 cells after 3 days by XTT assay |
CHEMBL1811802 |
NON-PROTEIN TARGET |
IC50 |
> |
10000.0 |
nM |
Cytotoxicity against human HeLaS3 cells after 3 days by XTT assay |
CHEMBL1811802 |
CCRF-CEM |
IC50 |
= |
3950.0 |
nM |
Cytotoxicity against human CCRF-CEM cells after 3 days by XTT assay |
CHEMBL1811802 |
Adenosine kinase |
IC50 |
> |
10000.0 |
nM |
Inhibition of human ADK using [3H]-adenosine by scintillation counting |
CHEMBL1811802 |
MRC5 |
CC50 |
= |
35100.0 |
nM |
Cytotoxicity against human MRC5 cells by MTT assay |
CHEMBL3352218 |
BJ |
CC50 |
= |
21200.0 |
nM |
Cytotoxicity against human BJ cells by MTT assay |
CHEMBL3352218 |
Adenosine kinase |
IC50 |
> |
10000.0 |
nM |
Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method |
CHEMBL3352218 |
Unchecked |
IC50 |
= |
1800.0 |
nM |
Inhibition of Mycobacterium tuberculosis ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method |
CHEMBL3352218 |
Mycobacterium bovis BCG |
IC50 |
= |
2270.0 |
nM |
Antimycobacterial activity against Mycobacterium bovis BCG assessed as microbial growth inhibition incubated for 21 days |
CHEMBL3352218 |
Mycobacterium tuberculosis H37Rv |
MIC |
= |
16000.0 |
nM |
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv My 331/88 assessed as microbial growth inhibition incubated for 14 days |
CHEMBL3352218 |
Mycobacterium tuberculosis |
MIC |
= |
16000.0 |
nM |
Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis Praha 131 assessed as microbial growth inhibition incubated for 14 days |
CHEMBL3352218 |
Unchecked |
Activity |
|
|
|
Activity of Mycobacterium tuberculosis ADK expressed in Escherichia coli BL21(DE3) cells assessed as compound phosphorylation by measuring conversion of compound to 5'-phosphate |
CHEMBL3352218 |
Dengue virus |
EC50 |
= |
13000.0 |
nM |
Antiviral activity against DENV |
CHEMBL5150000 |
Zika virus |
EC50 |
= |
2200.0 |
nM |
Antiviral activity against Zika virus |
CHEMBL5150000 |
NS5 |
IC50 |
= |
500.0 |
nM |
Inhibition of Zika virus RNA-dependent RNA polymerase |
CHEMBL5150000 |